| Baxter International, through its subsidiaries, provides a portfolio of healthcare products, including acute and chronic dialysis therapies; sterile intravenous solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision. Co. manages its business based on three geographic segments: Americas (North and South America), Europe, Middle East and Africa and Asia-Pacific. We show 40 historical shares outstanding datapoints in our BAX shares outstanding history coverage, used to compute BAX market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing BAX market cap history over the course of time is important for investors
interested in comparing BAX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of BAX versus a peer is one thing; comparing
BAX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like BAX can fluctuate over the course of history.
With this page we aim to empower investors researching BAX by allowing them to research the BAX market cap history.